spinout
The lead investigators have also spun out a company, Isabl, aiming to make the approach available to the broader community.
Engimmune Nets CHF 15.5M Seed Funding to Advance Cancer T-Cell Receptor Therapies
The ETH Zurich spinout plans to also use the funds to expand in Switzerland and gain a foothold in Denmark.
InnoSign Raises $8M in Series A Financing, Spins off From Royal Philips
The firm will use the proceeds to commercialize qPCR assays that use mRNA for pathway activity profiling.
The new firm, Blue Earth Therapeutics, is developing a PSMA-based radiopharmaceutical for prostate cancer that it plans to take into the clinic this summer.
Penn Spinout Verismo Therapeutics Trying to Skirt T-Cell Exhaustion in Cell Therapy for Solid Cancer
Premium
The firm has created a new construct dubbed "KIR-CAR," which they plan to begin evaluating next year in mesothelioma and ovarian cancer patients.